http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021036121-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2421ab6443978edca140d4d13106a407 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A24B15-167 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A24B15-16 |
| filingDate | 2019-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29fc734a89b4355489c35a33efbf779f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a658dc6d529bfd39f589d5912772e31c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35a4606cf725614cd5aa0d2fdb2ef10d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f55190316feaa989baa3e3fa32230b9 |
| publicationDate | 2021-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021036121-A1 |
| titleOfInvention | E-liquid |
| abstract | An e-liquid, comprising naringenin, wherein the content of naringenin in the e-liquid is 0.09% to 10% the total weight of the e-liquid. After the e-liquid is atomized, the naringenin contained therein may be atomized together with the e-liquid and absorbed by a human body, thereby achieving anti-inflammatory, cough-relieving and phlegm-eliminating effects, and inhibiting oral and respiratory bacteria. Moreover, the taste of the e-liquid after atomization is made more comfortable and milder, the aroma of the cigarette is enriched, and the quality of smoking is improved. |
| priorityDate | 2019-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.